Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 129

Sort by

Sort Order Select

Journal Articles

A Comprehensive Stratification Integrated the Clinical, Pathological, and Molecular Biological Features to Distinguish High-Risk Mantle Cell Lymphoma

Ping Yang, Chunyuan Li, Shuozi Liu, Yuan Yang, Weilong Zhang, Jing Wang, Yingtong Chen, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6305.

https://doi.org/10.1182/blood-2024-205002

Published: 2024

Journal Articles

Polatuzumab Vedotin As an Effective Salvage Therapy for Relapsed/Refractory Mantle Cell Lymphoma Resistantance to BTK and BCL Inhibitors

Ping Yang, Chunyuan Li, Yuan Yang, Shuozi Liu, Jing Wang, Yingtong Chen, Weilong Zhang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6303.

https://doi.org/10.1182/blood-2024-204939

Published: 2024

Journal Articles

TP53 Mutation Heterogeneity Reveals Distinct Prognoses in Mantle Cell Lymphoma

Shuozi Liu, Shaowei Zhou, Weilong Zhang, Jing Wang, Lingli Wang, Chunyuan Li, Yingtong Chen, Wenxin Qi, Ping Yang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6301.

https://doi.org/10.1182/blood-2024-204877

Published: 2024

Journal Articles

Sex Differences in Disease Characteristics and Outcome in Adults with Acute Myeloid Leukemia from China

Zongru Li, Lu Yu, Li-Juan Hu, Ting Zhao, Wenbing Duan, Jing Wang, Jinsong Jia, Jing Liu, Ya-Zhen Qin, Hao Jiang, Xiaohui Zhang, Feifei Tang, Yuqian Sun, XiaoDong Mo, Lanping Xu, Yu Wang, Xiaojun Huang, Qian Jiang

Blood (2024) 144 (Supplement 1): 6121.

https://doi.org/10.1182/blood-2024-211874

Published: 2024

Journal Articles

The Bone Marrow Blasts on Day 14 during the Azacitidine Plus Venetoclax Regimen As the Induction Therapy Can Predict the Outcome in Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia

Zongru Li, Lu Yu, Lijuan Hu, Ting Zhao, Wenbing Duan, Jing Wang, Jinsong Jia, Qiang Fu, Ya-Zhen Qin, Hao Jiang, Xiaohui Zhang, Feifei Tang, Yuqian Sun, XiaoDong Mo, Lanping Xu, Yu Wang, Xiaojun Huang, Qian Jiang

Blood (2024) 144 (Supplement 1): 4235.

https://doi.org/10.1182/blood-2024-209768

Published: 2024

Journal Articles

Five-Year Survival of Patients (pts) from Transcend NHL 001 (TRANSCEND) Supports Curative Potential of Lisocabtagene Maraleucel (liso-cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Jeremy S. Abramson, Maria Lia Palomba, Leo I. Gordon, Matthew Lunning, Michael Wang, Jon E. Arnason, Manali Kamdar, David G. Maloney, Mazyar Shadman, Charalambos Andreadis, Alison R. Sehgal, Scott R. Solomon, Nilanjan Ghosh, Juliana E. Hidalgo-López, Jing Wang, Ken Ogasawara, Ashvin Singh, Tanya Siddiqi

Blood (2024) 144 (Supplement 1): 3125.

https://doi.org/10.1182/blood-2024-200204

Published: 2024

Journal Articles

Protein Degrader WH25244 Eliminates Venetoclax Resistance Factors: Mutant or Hyperphosphorylated BCL2, and BCL-XL

Blood (2024) 144 (Supplement 1): 2786.

https://doi.org/10.1182/blood-2024-208159

Published: 2024

Journal Articles

Optimizing Treatment for Elderly Patients with NDMM Based on Frailty Assessment: A Real-World Observational Study

Hua Xue, Jianmei Xu, Jing Wang, Songying Zhao, Huimei Guo, Jiangbo Zhang, Jia Liu, Yao Liu

Blood (2024) 144 (Supplement 1): 2380.

https://doi.org/10.1182/blood-2024-200174

Published: 2024

Journal Articles

A New Frailty Assessment Model Incorporating Gait Speed and Grip Strength for Multiple Myeloma and Consistency Analysis with IMWG-FI

Hua Xue, Yan Su, Jianmei Xu, Jiangbo Zhang, Songying Zhao, Jing Wang, Huimei Guo, Jia Liu, Yao Liu

Blood (2024) 144 (Supplement 1): 3759.

https://doi.org/10.1182/blood-2024-206921

Published: 2024

Journal Articles

Selinexor Synergizes with Decitabine in Mantle Cell Lymphoma through MAPK Signaling Pathway

Yingtong Chen, Ping Yang, Weilong Zhang, Jing Wang, Shuang Gao, Yuan Yang, Shuozi Liu, Chunyuan Li, Hongmei Jing

Blood (2024) 144 (Supplement 1): 5845.

https://doi.org/10.1182/blood-2024-205492

Published: 2024

Journal Articles

Therapeutic Efficacy Analysis of 16 Patients with Primary Systemic Light Chain Amyloidosis Predominantly Exhibiting Advanced Cardiac Amyloidosis

Hua Xue, Jing Wang, Shaojie Ye, Huimei Guo, Songying Zhao, Jia Liu, Jiangbo Zhang, Jianmei Xu, Yao Liu

Blood (2024) 144 (Supplement 1): 7830.

https://doi.org/10.1182/blood-2024-204139

Published: 2024

Journal Articles

Dual-Risk Adjusted Therapy for Elderly Patients with Multiple Myeloma Based on Dynamic Frailty Assessment and R-ISS: A Prospective Clinical Trial

Hua Xue, Jianmei Xu, Jie Li, Xiaohui Suo, Haisheng Liu, Juan Wang, Jing Wang, Songying Zhao, Huimei Guo, Yao Liu

Blood (2024) 144 (Supplement 1): 7057.

https://doi.org/10.1182/blood-2024-200398

Published: 2024

Journal Articles

Multiparametric Flow Cytometry Combined with Multi-Mutated Genes Measurable Residual Disease Assessed By Droplet Digital PCR to Predict Relapse in Acute Myeloid Leukemia Patients: A Single Center Experience

Hua Xue, Shaojie Ye, Huimei Guo, Jianmei Xu, Xi Su, Lin Wang, Jiangbo Zhang, Jia Liu, Songying Zhao, Jing Wang, Yao Liu

Blood (2024) 144 (Supplement 1): 6166.

https://doi.org/10.1182/blood-2024-201879

Published: 2024

Journal Articles

UHRF1 Is a Promising Therapy Target in Aggressive Mantle Cell Lymphoma

Yuan Yang, Ping Yang, Weilong Zhang, Jing Wang, Yingtong Chen, Chunyuan Li, Hongmei Jing

Blood (2024) 144 (Supplement 1): 5753.

https://doi.org/10.1182/blood-2024-204870

Published: 2024

Journal Articles

MRD Evaluation in a Transplant-Eligible NDMM Study

Yuhe Peng, Chengcheng Fu, Song Jin, Jingjing Shang, Weiqin Yao, Zhi Yan, Yingying Zhai, Li Yao, Hongmiao Shen, Xingyue Wu, Hongying You, Yue Huang, Jing Wang, Jiao Lu, Depei Wu

Blood (2024) 144 (Supplement 1): 6995.

https://doi.org/10.1182/blood-2024-207983

Published: 2024

Journal Articles

Safety and Efficacy of Etoposide Combined with G-CSF for Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma

Huimei Guo, Jia Liu, Hua Xue, Songying Zhao, Jing Wang, Jianmei Xu, Jiangbo Zhang, Yao Liu

Blood (2024) 144 (Supplement 1): 2099.

https://doi.org/10.1182/blood-2024-204326

Published: 2024

Journal Articles

Global, Regional and National Burden of Leukemia, 1990-2021: Analysis of Data from the Global Burden of Disease Study 2021

Zhangjun Yun, Yayue Zhang, Jing Wang, Chengyuan Xue, Jieya Wu, Xinpu Han, Zhu Liu, Yu Zhang, Yubo Qi, Li Hou

Blood (2024) 144 (Supplement 1): 7907.

https://doi.org/10.1182/blood-2024-205478

Published: 2024

Journal Articles

The Significance and Predictive Performance of Gait Speed and Grip Strength in Frailty Assessment of Newly Diagnosed DLBCL

Hua Xue, Jiangbo Zhang, Jing Wang, Songying Zhao, Huimei Guo, Jia Liu, Jianmei Xu, Yao Liu

Blood (2024) 144 (Supplement 1): 6459.

https://doi.org/10.1182/blood-2024-202228

Published: 2024

Journal Articles

Exploring Droplet Digtial PCR Detection of MYD88 L265P mutation Burden for the Evaluation of Efficacy in Patients with WM : A Convenient and Accurate Supplementary Approach to IMWG-11 Criteria

Hua Xue, Wenjie Li, Songying Zhao, Jing Wang, Huimei Guo, Jia Liu, Jiangbo Zhang, Jianmei Xu, Yao Liu

Blood (2024) 144 (Supplement 1): 6330.

https://doi.org/10.1182/blood-2024-202497

Published: 2024

Journal Articles

Prognostic Significance of POD24 and Monoclonal Paraproteinemia in Extranodal MZL

Lingli Wang, Jinjie Gao, Wei Wan, Fei Dong, Jing Wang, Weilong Zhang, Ping Yang, Lan Ma, Wei Zhao, Jijun Wang, Hongmei Jing

Blood (2024) 144 (Supplement 1): 6340.

https://doi.org/10.1182/blood-2024-205570

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A Comprehensive Stratification Integrated the Clinical, Pathological, and Molecular Biological Features to Distinguish High-Risk Mantle Cell Lymphoma

Polatuzumab Vedotin As an Effective Salvage Therapy for Relapsed/Refractory Mantle Cell Lymphoma Resistantance to BTK and BCL Inhibitors

TP53 Mutation Heterogeneity Reveals Distinct Prognoses in Mantle Cell Lymphoma

Sex Differences in Disease Characteristics and Outcome in Adults with Acute Myeloid Leukemia from China

The Bone Marrow Blasts on Day 14 during the Azacitidine Plus Venetoclax Regimen As the Induction Therapy Can Predict the Outcome in Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia

Five-Year Survival of Patients (pts) from Transcend NHL 001 (TRANSCEND) Supports Curative Potential of Lisocabtagene Maraleucel (liso-cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Protein Degrader WH25244 Eliminates Venetoclax Resistance Factors: Mutant or Hyperphosphorylated BCL2, and BCL-XL

Optimizing Treatment for Elderly Patients with NDMM Based on Frailty Assessment: A Real-World Observational Study

A New Frailty Assessment Model Incorporating Gait Speed and Grip Strength for Multiple Myeloma and Consistency Analysis with IMWG-FI

Selinexor Synergizes with Decitabine in Mantle Cell Lymphoma through MAPK Signaling Pathway

Therapeutic Efficacy Analysis of 16 Patients with Primary Systemic Light Chain Amyloidosis Predominantly Exhibiting Advanced Cardiac Amyloidosis

Dual-Risk Adjusted Therapy for Elderly Patients with Multiple Myeloma Based on Dynamic Frailty Assessment and R-ISS: A Prospective Clinical Trial

Multiparametric Flow Cytometry Combined with Multi-Mutated Genes Measurable Residual Disease Assessed By Droplet Digital PCR to Predict Relapse in Acute Myeloid Leukemia Patients: A Single Center Experience

UHRF1 Is a Promising Therapy Target in Aggressive Mantle Cell Lymphoma

MRD Evaluation in a Transplant-Eligible NDMM Study

Safety and Efficacy of Etoposide Combined with G-CSF for Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma

Global, Regional and National Burden of Leukemia, 1990-2021: Analysis of Data from the Global Burden of Disease Study 2021

The Significance and Predictive Performance of Gait Speed and Grip Strength in Frailty Assessment of Newly Diagnosed DLBCL

Exploring Droplet Digtial PCR Detection of MYD88 L265P mutation Burden for the Evaluation of Efficacy in Patients with WM : A Convenient and Accurate Supplementary Approach to IMWG-11 Criteria

Prognostic Significance of POD24 and Monoclonal Paraproteinemia in Extranodal MZL

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only